Ethema Health (OTCMKTS:GRST) and Chemed (NYSE:CHE) Head to Head Review

Ethema Health (OTCMKTS:GRST) and Chemed (NYSE:CHE) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings.

Analyst Recommendations

This is a summary of recent recommendations for Ethema Health and Chemed, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ethema Health	0	0	0	0	0.00
Chemed	0	5	1	0	2.17

Chemed has a consensus target price of $530.75, suggesting a potential downside of 2.36%. Given Ethema Health’s higher possible upside, equities research analysts plainly believe Ethema Health is more favorable than Chemed.

Institutional and Insider Ownership

95.8% of Chemed shares are owned by institutional investors. 55.7% of Ethema Health shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Ethema Health and Chemed”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ethema Health	$18.76 million	0.00	-$2.18 million	N/A	N/A
Chemed	$2.53 billion	2.81	$265.24 million	$19.91	27.30

Chemed has higher revenue and earnings than Ethema Health.

Profitability

This table compares Ethema Health and Chemed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ethema Health	-11.61%	N/A	-7.48%
Chemed	10.60%	31.77%	18.90%

Risk and Volatility

Ethema Health has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500.

Summary

Chemed beats Ethema Health on 8 of the 11 factors compared between the two stocks.

About Ethema Health

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.